on 06 Feb 2024
Last Applicant/ Owned by
MULLAGHARLIN,
DUNDALK, CO LOUTH
IE
A91X56F
Serial Number
97436004 filed on 31st May 2022
Registration Number
7300666 registered on 06th Feb 2024
Correspondent Address
Michael T. Smith
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Product development for others; pharmaceutical drug developments services; scientific research and development; pharmaceutical research; research and development of new products; consulting services in the field of pharmaceutical technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and developmen Read More
Product development for others; pharmaceutical drug developments services; scientific research and development; pharmaceutical research; research and development of new products; consulting services in the field of pharmaceutical technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies
31st Mar 2023
31st Mar 2023
Custom manufacture of pharmaceuticals by pharmaceutical compounders; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Custom manufacture of nutraceuticals by pharmaceutical compounders; Custom manufacture of vitamins for humans
31st Mar 2023
31st Mar 2023
No 97436004
No Service Mark
No 0904-0203US1
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Feb 2024 | REGISTERED-PRINCIPAL REGISTER |
06th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
30th Dec 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
29th Dec 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
18th Aug 2023 | STATEMENT OF USE PROCESSING COMPLETE |
10th Aug 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
31st Jul 2023 | TEAS STATEMENT OF USE RECEIVED |
31st Jul 2023 | USE AMENDMENT FILED |
31st Jan 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
06th Dec 2022 | PUBLISHED FOR OPPOSITION |